Active

FASE

Switched

BE0552649283

Rechtspersoon Private limited company 1 establishment

Steenweg 242, 9810 Nazareth-De Pinte Vervaardiging van overige farmaceutische producten

Active for

12 year, 4 months

Financials

Financial year 2025

Worth noting

  • Little cash and receivables against the short-term debts.

Gross margin

€ 117,233

▲ 26% vs 2024

Profit

Growing

€ 33,055

▲ 274% vs 2024

Debts

Low

€ 1.4 million

▼ 6% vs 2024

FASE from Nazareth-De Pinte, company number BE0552649283, closed financial year 2025 with a result of € 33,055 after tax. For that financial year FASE recorded a gross margin of € 117,233 and equity of € 1 million. Compared with financial year 2024, the result moved from € 8,848 to € 33,055. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 26, 2026.

What happened at FASE?

What happened at FASE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 33,055 (▲ 274% vs 2024). Source: NBB ↗
  • New establishment in Nazareth-De Pinte. KBO
  • Katrien De Loof became a director. NBB
  • Bart de craene became a director. NBB
  • Start of the company according to the CBE. KBO

In short

From € 135,667 profit in 2021 to € 33,055 profit in 2025.

Paid € 81,397 in corporate taxes since 2021.

Best year ever: 2021, with € 135,667 profit.

Paid out € 8,250 in dividends to the owners in total.

A new publication or filing at FASE? We notify you, reason included.

Follow FASE

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Katrien De Loof
Bart de craene
FASE

Behind FASE are Katrien De Loof and Bart de craene. It owns 100% of Apotheek Gopharma and 99% of Apotheek Pharmago itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Katrien De Loof

Director

Also active at: Wijkgezondheidscentrum Nieuw Gent, APOTHEEK PHARMAGO

since 2014

Bart de craene

Director

Also active at: APOTHEEK GOPHARMA

since 2014

Establishments

Establishment units

Physical locations of this company

Registered office

Steenweg 242

9810 Nazareth-De Pinte

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

Details

Company number
0552.649.283
VAT number
BE 0552.649.283
Registered office
Steenweg 242, 9810 Nazareth-De Pinte
Names & denominations
FASE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
8 May 2014
Peppol
Active · Active since 27 May 2025
Activities · NACE

Vervaardiging van overige farmaceutische producten

Frequently asked questions

What is the enterprise number of FASE?
The enterprise number of FASE is BE0552649283.
What is the address of FASE?
The registered office of FASE is located at Steenweg 242, 9810 Nazareth-De Pinte.
When was FASE founded?
FASE was founded on 8 May 2014.
What is the main activity of FASE?
The main activity of FASE is "Vervaardiging van overige farmaceutische producten" (NACE code 21209).
Does FASE have a website?
No website is currently known for FASE.
How much profit did FASE make in 2025?
FASE posted a profit after taxes of € 33,055 in financial year 2025.
What is the revenue of FASE?
As a small company, FASE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 117,233.
Where can I find the annual accounts of FASE?
FASE files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of FASE?
According to the 2025 annual accounts, the directors of FASE are: Katrien De Loof, Bart de craene.
Who owns FASE?
Behind FASE are Katrien De Loof and Bart de craene. It owns 100% of Apotheek Gopharma and 99% of Apotheek Pharmago itself.